cti-mcp
Provides access to Naver Finance market data for Korean pharma/biotech stocks, including OHLCV price data and technical indicators (RSI, Bollinger Bands, Volume).
Click on "Deploy Server".
Wait a few minutes for the server to deploy. Once ready, it will show a "Started" state.
In the chat, type
@followed by the MCP server name and your instructions, e.g., "@cti-mcp Analyze stock 068270"
That's it! The server will respond to your query, and you can continue using it as needed.
Here is a step-by-step guide with screenshots.
CTI Pharma Analyzer
한국 제약/바이오 임상시험 기반 주가 분석 도구
ClinicalTrials.gov 임상시험 데이터와 Naver Finance 공개 시장 데이터를 활용하여 한국 제약/바이오 종목을 분석합니다. 100점 만점 스코어링, 의사결정 라벨, 기술적 지표를 제공합니다. KIS API 불필요.
Clinical trial intelligence for Korean pharma stocks.
Analyzes Korean pharma/biotech stocks using ClinicalTrials.gov data and Naver Finance public market data. Provides 100-point scoring, decision labels, and technical indicators. No KIS API required.
설치 / Installation
Claude Code 플러그인 (권장 / Recommended)
claude plugin add github:hjsh200219/trading-by-clinical-trial설치하면 MCP 서버(cti-mcp)가 자동 연결되고, 스킬을 바로 사용할 수 있습니다. 별도 설치 불필요.
Installs the plugin with MCP server auto-connected. No additional setup required.
MCP 서버 직접 연결 (Claude Desktop / Claude Code)
claude_desktop_config.json 또는 .mcp.json에 추가:
{
"mcpServers": {
"cti-mcp": {
"type": "url",
"url": "https://clinical-trials-mcp.up.railway.app/mcp"
}
}
}Related MCP server: StockLens
사용법 / Usage
Claude Code 플러그인 스킬
스킬 | 설명 | Description |
| 종합 분석 (임상+시장+스코어+경쟁) | Full analysis with scoring and competition |
| 6개 컴포넌트 상세 스코어링 | Detailed 100-point score breakdown |
| 경쟁 환경 분석 | Competitive landscape mapping |
| 카탈리스트 추적 | Upcoming trial completion events |
| 파이프라인 총괄 랭킹 | Pipeline overview ranked by trials |
| RSI/Bollinger/Volume 기술적 지표 | Technical indicators |
사용 예시 / Examples:
셀트리온 임상 분석해줘
068270 스코어 알려줘
한국 제약 파이프라인 현황 보여줘
3개월 이내 Phase 3 카탈리스트 목록
유방암 경쟁 환경 분석
알테오젠 기술적 지표MCP 서버 도구
도구 | 설명 | 주요 파라미터 |
| 종합 분석 |
|
| 임상시험 검색 |
|
| 스코어 분석 |
|
| 경쟁 분석 |
|
| 카탈리스트 |
|
| 파이프라인 |
|
| 기술적 지표 |
|
Examples:
analyze_stock({ symbol: "068270" }) // 셀트리온
score_stock({ symbol: "207940" }) // 삼성바이오로직스
get_upcoming_catalysts({ months: 3, phase: "Phase 3" })
get_kr_pharma_pipeline({ top: 10 })
get_competition_analysis({ condition: "Breast Cancer" })
get_stock_technicals({ symbol: "196170" }) // 알테오젠스코어링 (100점) / Scoring
컴포넌트 | 점수 | 설명 | Description |
Temporal Proximity | 30 | 완료까지 남은 시간 | Time to trial completion |
Impact | 25 | Phase 및 등록 규모 | Phase and enrollment size |
Market Signal | 15 | 기술적 지표 | RSI, Bollinger, Volume |
Competition | 15 | 글로벌 경쟁 환경 | Global competitor landscape |
Pipeline | 10 | 활성 임상 포트폴리오 | Active trial portfolio |
Data Richness | 5 | 메타데이터 완성도 | Metadata completeness |
의사결정 라벨 / Decision Labels
라벨 | 의미 | Meaning |
🟢 | 강한 긍정 신호 | High-confidence positive signal |
🟩 | 긍정 신호 | Positive trial signal |
🟡 | 중립 | Insufficient signal strength |
🟠 | 모니터링 대상 | Worth monitoring, not actionable |
🔵 | 결과 검토 필요 | Results posted, manual review needed |
🔴 | 부정 신호 | Negative signal |
기술적 지표 / Technical Indicators
지표 | 방법 | 해석 |
RSI (14) | Wilder's smoothing | < 30 과매도 / 30-70 중립 / > 70 과매수 |
Bollinger %B | 20일 SMA, 2σ | 밴드 내 위치 (0%=하단, 100%=상단) |
Volume Ratio | 당일 / 20일 평균 | < 0.5 저조 / 0.5-1.5 정상 / > 3.0 급증 |
커버리지 / Coverage
셀트리온, 삼성바이오로직스, SK바이오팜, 유한양행, 대웅제약, 한미약품, 녹십자, 알테오젠, ABL바이오 등 32개 한국 제약/바이오 기업.
32 Korean pharma/biotech companies including Celltrion, Samsung Biologics, SK Biopharmaceuticals, Yuhan, Daewoong, Hanmi, Green Cross, Alteogen, ABL Bio, and more.
데이터 소스 / Data Sources
소스 | 데이터 | Data |
ClinicalTrials.gov API v2 | 임상시험 메타데이터 | Trial metadata, phases, enrollment |
Naver Finance (fchart) | OHLCV 가격 데이터 | Price data for KRX (KOSPI/KOSDAQ) |
미제공 (KIS API 없음): 기관 수급, 공매도 비율, 실시간 호가
개발 / Development
로컬에서 직접 빌드하여 MCP 서버를 실행할 수도 있습니다.
You can also build and run the MCP server locally.
git clone https://github.com/hjsh200219/trading-by-clinical-trial.git
cd trading-by-clinical-trial
npm install
npm run build
npm test # 186 testsclaude_desktop_config.json에 로컬 서버 등록:
{
"mcpServers": {
"cti-mcp": {
"command": "node",
"args": ["/absolute/path/to/trading-by-clinical-trial/dist/index.js"]
}
}
}임상시험 메타데이터와 공개 시장 데이터에 기반한 분석입니다. 투자 조언이 아닙니다.
Analysis based on clinical trial metadata and public market data. Not financial advice.
Available Tools
10 toolsanalyze_stockB
Full clinical trial + market analysis for a Korean pharma company. Provide symbol (e.g. "005930") or sponsor name.
Inputs: symbol, sponsor.
evaluate_trading_signalA
Evaluate a trading signal using the 10-combo scoring engine. Provide institutional/foreign/short-selling data to get STRONG_BUYAVOID grade with expected return and win rate. Data represents a D-60 to D-day window split into early (D-60D-30) and late (D-30~D-day) halves.
Inputs: data_points (required), foreign_net_late (required), foreign_net_early (required), short_selling_late (required), +5 more.
get_competition_analysisB
Map the competitive landscape for a given condition or specific trial. Returns all competing sponsors.
Inputs: nct_id, condition, exclude_sponsor.
get_kr_pharma_pipelineC
Overview of Korean pharma pipeline ranked by number of active clinical trials.
Inputs: top, phase.
get_stock_technicalsB
Get technical indicators (RSI, Bollinger Bands, Volume Ratio) for a Korean pharma stock.
Inputs: symbol (required), range.
get_technical_strategiesB
Run 5 advanced technical analysis strategies (Elder BBP, SuperTrend Pullback, ICT IFVG, RC Bollinger Reversal, RC Divergence) and produce a consensus signal for a Korean pharma stock.
Inputs: symbol (required), range.
get_upcoming_catalystsB
List upcoming clinical trial catalysts (completion dates) for Korean pharma companies within the next N months.
Inputs: phase, months, symbol.
pingA
Health check — returns pong
Inputs: no named parameters.
score_stockB
Score breakdown for a Korean pharma company — shows all 6 scoring components and the decision.
Inputs: symbol, sponsor.
search_pharma_trialsA
Search ClinicalTrials.gov for Korean pharma company trials. Resolves symbol to sponsor names automatically.
Inputs: phase, status, symbol, keyword, +1 more.
Tool Schema Changelog
Recent tool additions, removals, and schema changes observed during successful MCP inspections.
Loading tool schema changelog…
TDQS
Scored across 10 tools
Most tools have clearly distinct purposes, but there is slight overlap between get_upcoming_catalysts and get_kr_pharma_pipeline (both relate to clinical trials) and between evaluate_trading_signal and score_stock (both produce scores). Descriptions help clarify the differences, but an agent might occasionally misselect.
The majority of tools follow a get_* pattern, but there are deviations like evaluate_trading_signal, search_pharma_trials, score_stock, and ping. All use snake_case consistently, so the naming is readable and predictable, just not perfectly uniform.
10 tools is a well-scoped number for a server covering both clinical trial data and technical stock analysis. Each tool serves a distinct function, and there is no unnecessary bloat or deficiency.
The tool set covers the full range of the domain: clinical trial catalysts, pipeline overview, trial search, technical indicators, advanced strategies, signal evaluation, scoring breakdown, competition analysis, and a comprehensive analyze_stock wrapper. No obvious gaps in the workflow.
Maintenance
Related MCP Connectors
Market analyst tools + AI agent: crypto, US equities, options, Korea, fundamentals, macro, backtests
Korean (DART/KIND) and US SEC filings with AI summaries, direction labels and market reaction.
Korean stocks (KOSPI/KOSDAQ): DART filing summaries, value chains, disclosures, news, IPOs. No key.
Search company disclosures and financial statements from the Korean market. Retrieve stock profile…
Related MCP Servers
- AlicenseNot gradedqualityFmaintenanceProvides access to Korean financial news and market data (stocks and crypto) with AI-ready mathematical scoring to prevent hallucinations. Includes tools for news retrieval, chart analysis, financial statements, tag matching, and trend analysis.67 npm5MIT
- AlicenseAqualityBmaintenanceProvides AI with real-time stock data from Naver Securities and Yahoo Finance via 47 tools, enabling accurate analysis without API keys for Korean and US markets.72Academic Free v1.1
- FlicenseAqualityBmaintenanceEnables searching and analyzing Korean stocks using Richgo Finance data, including stock details, rankings, undervaluation, AI rankings, and curation screens.11-
- AlicenseNot gradedqualityDmaintenanceEnables AI-powered analysis of Korean stock market data and corporate disclosures using official DART and KRX APIs.190 npmISC